Intranasal corticosteroids for nasal polyposis : biological rationale, efficacy, and safety.

Niels Mygind, Valerie Lund
{"title":"Intranasal corticosteroids for nasal polyposis : biological rationale, efficacy, and safety.","authors":"Niels Mygind,&nbsp;Valerie Lund","doi":"10.2165/00151829-200605020-00003","DOIUrl":null,"url":null,"abstract":"<p><p>Nasal polyposis, occurring in about 2% of the general population, is the ultimate form of inflammation of the upper airways. For unknown reasons, polyps develop preferentially in subtypes of inflammatory diseases and are associated with perennial non-allergic rhinitis, asthma, intolerance of aspirin (acetylsalicylic acid)/NSAIDs, allergic fungal rhinosinusitis, cystic fibrosis, and primary ciliary dyskinesia. In contrast to common beliefs, IgE-mediated allergy does not seem to play an etiological role in nasal polyposis.The polyps originate from the mucosa around the clefts of the lateral nasal wall, especially in the region of the ostiomeatal complex. The factors that determine the localization of the disease to a few square centimeters of the airways are not known.Polyps are edematous bags covered by respiratory epithelium and contain very few nerves, blood vessels, and glands that have undergone cystic degeneration. They contain degranulated mast cells, have a very high concentration of histamine, and are characteristically infiltrated by eosinophils. These cells accumulate due to the release of proinflammatory cytokines (in particular, interleukin-5).Nasal polyposis is preceded by a prolonged history of rhinitis accompanied by severe and persistent nasal blockage; typically, the sense of smell is seriously impaired when polyps develop. The diagnosis is based on anterior rhinoscopy or, preferably, endoscopy.Nasal polyposis is medically treatable. Surgical treatment is carried out when medication fails. Intranasal corticosteroids reduce rhinitis symptoms, improve nasal breathing, reduce the size of polyps, and prevent, in part, their recurrence, but this treatment has little effect on the sense of smell. Intranasal corticosteroids can, as basic long-term therapy, be used alone in mild cases or together with systemic corticosteroids and/or surgery in severe cases. Systemic corticosteroids administered for 2-3 weeks have a beneficial effect on all observed symptoms and pathology, including the sense of smell. When nasal blockage is a problem in spite of medical treatment, surgery is recommended. Simple polypectomy can be performed, but endoscopic surgery is recommended in more severe and persistent cases.</p>","PeriodicalId":87162,"journal":{"name":"Treatments in respiratory medicine","volume":"5 2","pages":"93-102"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2165/00151829-200605020-00003","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Treatments in respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00151829-200605020-00003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

Nasal polyposis, occurring in about 2% of the general population, is the ultimate form of inflammation of the upper airways. For unknown reasons, polyps develop preferentially in subtypes of inflammatory diseases and are associated with perennial non-allergic rhinitis, asthma, intolerance of aspirin (acetylsalicylic acid)/NSAIDs, allergic fungal rhinosinusitis, cystic fibrosis, and primary ciliary dyskinesia. In contrast to common beliefs, IgE-mediated allergy does not seem to play an etiological role in nasal polyposis.The polyps originate from the mucosa around the clefts of the lateral nasal wall, especially in the region of the ostiomeatal complex. The factors that determine the localization of the disease to a few square centimeters of the airways are not known.Polyps are edematous bags covered by respiratory epithelium and contain very few nerves, blood vessels, and glands that have undergone cystic degeneration. They contain degranulated mast cells, have a very high concentration of histamine, and are characteristically infiltrated by eosinophils. These cells accumulate due to the release of proinflammatory cytokines (in particular, interleukin-5).Nasal polyposis is preceded by a prolonged history of rhinitis accompanied by severe and persistent nasal blockage; typically, the sense of smell is seriously impaired when polyps develop. The diagnosis is based on anterior rhinoscopy or, preferably, endoscopy.Nasal polyposis is medically treatable. Surgical treatment is carried out when medication fails. Intranasal corticosteroids reduce rhinitis symptoms, improve nasal breathing, reduce the size of polyps, and prevent, in part, their recurrence, but this treatment has little effect on the sense of smell. Intranasal corticosteroids can, as basic long-term therapy, be used alone in mild cases or together with systemic corticosteroids and/or surgery in severe cases. Systemic corticosteroids administered for 2-3 weeks have a beneficial effect on all observed symptoms and pathology, including the sense of smell. When nasal blockage is a problem in spite of medical treatment, surgery is recommended. Simple polypectomy can be performed, but endoscopic surgery is recommended in more severe and persistent cases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鼻内皮质类固醇治疗鼻息肉病:生物学原理、疗效和安全性。
鼻息肉病是上呼吸道炎症的最终形式,约占总人口的2%。由于未知的原因,息肉优先发生在炎症性疾病亚型中,并与常年性非过敏性鼻炎、哮喘、阿司匹林(乙酰水杨酸)/非甾体抗炎药不耐受、过敏性真菌性鼻窦炎、囊性纤维化和原发性纤毛运动障碍相关。与普遍的看法相反,ige介导的过敏似乎并不在鼻息肉病中起病因学作用。息肉起源于鼻外侧壁间隙周围的粘膜,特别是在口鼻道复合体区域。决定疾病局限于气道几平方厘米的因素尚不清楚。息肉是由呼吸上皮覆盖的水肿袋,包含很少的神经、血管和囊性变性的腺体。它们含有脱颗粒肥大细胞,具有非常高浓度的组胺,并以嗜酸性粒细胞浸润为特征。这些细胞的积累是由于促炎细胞因子(特别是白细胞介素-5)的释放。鼻息肉病之前有长期的鼻炎病史,并伴有严重和持续的鼻阻塞;通常,当息肉形成时,嗅觉会严重受损。诊断是基于前鼻镜检查,或者最好是内窥镜检查。鼻息肉病是可以医学治疗的。药物治疗无效时进行手术治疗。鼻内皮质类固醇可减轻鼻炎症状,改善鼻腔呼吸,缩小息肉的大小,并在一定程度上防止其复发,但这种治疗对嗅觉几乎没有影响。鼻内皮质类固醇可作为基本的长期治疗,在轻度病例中单独使用,或在严重病例中与全身皮质类固醇和/或手术联合使用。全体性皮质类固醇给予2-3周对所有观察到的症状和病理,包括嗅觉有有益的影响。当药物治疗后鼻塞仍有问题时,建议手术治疗。简单的息肉切除术可以进行,但在更严重和持续的情况下,建议内镜手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Idiopathic Pulmonary Fibrosis Nosocomial pneumonia : rationalizing the approach to empirical therapy. Managing asthma in expectant mothers. New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy. Antioxidant strategies in respiratory medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1